Americans look to Canada for lower drug prices, but are they getting the full picture?: Nigel Rawson and John Adams in The Hill
This article originally appeared in The Hill. The full article can be read here. By Nigel Rawson and John Adams, ...
Tag: drug policy
Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy
This article is the fifth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy
This article is the fourth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy
This article is the third part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy
This article is the second part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Top News
-
Medical organizations and media let Canadians believe gender medicine is safe and universally accepted. It’s not: 14 physicians author statement for Inside Policy
-
Hybrid threats, broken borders, and organized chaos—transnational organized crime in Canada: Inside Policy Q&A with Cal Chrustie
-
Fighting mortgage fraud in Canada: Cameron Field
-
Canada at a Crossroads – Volume 5: Proud and free – Rebuilding Canada’s heritage and national identity
-
Canada should harness its AI advantage, not squander it: Lawrence Zhang and Daniel Castro
